Neuroscience and cancer research added to statewide priorities: about $61 million awarded to URI since program began in 2001. Brown University, Rhode Island College, Providence College, Bryant University, Roger Williams University, Salve Regina University and CCRI are partners in RI-INBRE program.

CSHL ramps up licensing of its short-hairpin RNA technology already used widely in cancer research and drug development.

Not all cancer cells are created equal – some stay put in the primary tumor, while others move and invade elsewhere. A major goal for cancer research is predicting which cells will metastasize, and why

Researchers have created a prototype system that uses a mathematical model to predict - and a portable inkjet technology to produce - precise medication dosages tailored for specific patients, an advance in personalized medicine that could improve drug effectiveness and reduce adverse reactions.

Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.

Work in mice advances potential for nanoparticles to treat brain cancer.

Researchers from the University of Rhode Island are championing a recent breakthrough in the laboratory with hopes it could lead to a vaccine against the pathogen responsible for stomach cancer and to therapeutics for inflammatory diseases.

Engineering breakthrough will allow cancer researchers to create live tumors with a 3D printer 

Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.

UD researchers demonstrate that processing can affect size of nanocarriers for targeted drug delivery.